worldwide offices | stay connected | contact | help | sitemap

 
 

 

 

 

Novartis Research and Development (R&D)

Novartis Research and Development (R&D)

Drug discovery and development process 

Our interactive chart shows the various steps of drug discovery and development, from target selection to registration.

Novartis Institutes for BioMedical Research (NIBR)

Novartis Institutes for BioMedical Research (NIBR) 

The Novartis Institutes for BioMedical Research (NIBR) is a global research organization committed to discovering innovative medicines that treat disease and improve human health.

Pharmaceutical Development 

Novartis Pharmaceutical Development evaluates drug candidates and proves them to be high-quality therapies with superior value to patients.

Novartis Biologics

Novartis Biologics 

As part of Pharmaceutical Development, Novartis Biologics is dedicated to delivering targeted biologic therapies that can improve the lives of patients around the world.

Corporate Research

Novartis Institute for Tropical Diseases (NITD) 

Discovering new treatments and prevention methods for major tropical diseases: dengue, tuberculosis, malaria.

Novartis Vaccines Institute for Global Health (NVGH) 

Focusing on translational R&D to develop vaccines for neglected infectious diseases.

Genomics Institute of the Novartis Research Foundation (GNF) 

Contributing to new therapeutic targets, technologies and drug discovery.

Friedrich Miescher Institute for Biomedical Research (FMI) 

Discovering basic molecular mechanisms of cells and organisms in health and disease.

Corporate Research locations

Research locations 

Discover our research locations worldwide.

 

During 2008, Novartis increased research and development investments by 12% to USD 7.2 billion. This is one of the highest figures in the industry relative to sales (17.4%).

In 2008, our access-to-medicines programs, valued at USD 1.26 billion, reached 74 million patients.

About Novartis

About Novartis

We provide medicines to treat and prevent diseases, ease suffering and improve quality of life.

Inventor of the Year Award

Scientists who developed Novartis Coartem and Glivec receive 2009 ''European Inventor of the Year'' awards.

Latest news

Careers

Our success depends on the creativity and performance of our associates.